Wong MCS, Jiang JY, Liang M, Fang Y, Yeung MS, Sung JJY (2017) Global temporal patterns of pancreatic cancer and association with socioeconomic development. Sci Rep 7:3165

PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17–48

PubMed  Google Scholar 

Stoffel EM, Brand RE, Goggins M (2023) Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology 164:752–765

PubMed  Google Scholar 

Salas JR, Clark PM (2022) Signaling pathways that drive (18)F-FDG accumulation in cancer. J Nucl Med 63:659–663

CAS  PubMed  Google Scholar 

Khadka R, Tian W, Hao X, Koirala R (2018) Risk factor, early diagnosis and overall survival on outcome of association between pancreatic cancer and diabetes mellitus: Changes and advances, a review. Int J Surg 52:342–346

PubMed  Google Scholar 

Zimny M, Bares R, Fass J et al (1997) Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur J Nucl Med 24:678–682

CAS  PubMed  Google Scholar 

Franco OE, Shaw AK, Strand DW, Hayward SW (2010) Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 21:33–39

CAS  PubMed  Google Scholar 

Mao X, Xu J, Wang W et al (2021) Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer 20:131

CAS  PubMed  PubMed Central  Google Scholar 

Biffi G, Tuveson DA (2021) Diversity and biology of cancer-associated fibroblasts. Physiol Rev 101:147–176

CAS  PubMed  Google Scholar 

Mezawa Y, Orimo A (2022) Phenotypic heterogeneity, stability and plasticity in tumor-promoting carcinoma-associated fibroblasts. Febs J 289:2429–2447

CAS  PubMed  Google Scholar 

Jacob M, Chang L, Puré E (2012) Fibroblast activation protein in remodeling tissues. Curr Mol Med 12:1220–1243

CAS  PubMed  Google Scholar 

Zhao L, Chen J, Pang Y et al (2022) Fibroblast activation protein-based theranostics in cancer research: a state-of-the-art review. Theranostics 12:1557–1569

CAS  PubMed  PubMed Central  Google Scholar 

Pang Y, Zhao L, Shang Q et al (2022) Positron emission tomography and computed tomography with [(68)Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer. Eur J Nucl Med Mol Imaging 49:1322–1337

CAS  PubMed  Google Scholar 

McInnes MDF, Moher D, Thombs BD et al (2018) Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA 319:388–396

PubMed  Google Scholar 

Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536

PubMed  Google Scholar 

Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560

PubMed  PubMed Central  Google Scholar 

Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 27:1785–1805

PubMed  Google Scholar 

Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135

PubMed  PubMed Central  Google Scholar 

Zhao L, Pang Y, Luo Z et al (2021) Role of [(68)Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [(18)F]-FDG PET/CT. Eur J Nucl Med Mol Imaging 48:1944–1955

CAS  PubMed  Google Scholar 

Zhang Z, Jia G, Pan G et al (2022) Comparison of the diagnostic efficacy of (68) Ga-FAPI-04 PET/MR and (18)F-FDG PET/CT in patients with pancreatic cancer. Eur J Nucl Med Mol Imaging 49:2877–2888

CAS  PubMed  Google Scholar 

Ding J, Qiu J, Hao Z et al (2023) Comparing the clinical value of baseline [(68) Ga]Ga-FAPI-04 PET/CT and [(18)F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis. Eur J Nucl Med Mol Imaging. https://doi.org/10.1007/s00259-023-06297-y

Liu Q, Shi S, Liu S et al (2023) The added value of [(68)Ga]Ga-DOTA-FAPI-04 PET/CT in pancreatic cancer: a comparison to [(18)F]F-FDG. Eur Radiol 33:5007–5016

CAS  PubMed  Google Scholar 

Lyu Z, Han W, Zhang Q et al (2023) Clinical application of Al(18)F-NOTA-FAPI PET/CT in diagnosis and TNM staging of pancreatic adenocarcinoma, compared to (18)F-FDG. Cancer Imaging 23:86

PubMed  PubMed Central  Google Scholar 

Novruzov E, Giesel FL, Mori Y et al (2023) Head-to-head intra-individual comparison of biodistribution and tumor uptake of [(18)F]FAPI-74 with [(18)F]FDG in patients with PDAC: a prospective exploratory study. Cancers (Basel). https://doi.org/10.3390/cancers15102798

Pang Y, Zhao L, Meng T et al (2023) PET imaging of fibroblast activation protein in various types of cancer using (68)Ga-FAP-2286: comparison with (18)F-FDG and (68)Ga-FAPI-46 in a single-center, prospective study. J Nucl Med 64:386–394

CAS  PubMed  PubMed Central  Google Scholar 

Watabe T, Naka S, Tatsumi M et al (2023) Initial evaluation of [(18)F]FAPI-74 PET for various histopathologically confirmed cancers and benign lesions. J Nucl Med 64:1225–1231

CAS  PubMed  PubMed Central  Google Scholar 

Veldhuijzen van Zanten SEM, Pieterman KJ, Wijnhoven BPL et al (2022) FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances. Diagnostics (Basel) 12:1958

Huang D, Wu J, Zhong H et al (2023) [68Ga]Ga-FAPI PET for the evaluation of digestive system tumors: systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 50:908–920

Ouyang J, Ding P, Zhang R, Lu Y (2023) Head-to-head comparison of (68)Ga-FAPI-04 PET/CT and (18)F-FDG PET/CT in the evaluation of primary digestive system cancer: a systematic review and meta-analysis. Front Oncol 13:1202505

CAS  PubMed  PubMed Central  Google Scholar 

Matsumoto T, Okabe H, Yamashita YI et al (2019) Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography ((18)F-FDG PET/CT) in patients with pancreatic neuroendocrine tumors. Surg Today 49:21–26

CAS  PubMed  Google Scholar 

Panagiotidis E, Alshammari A, Michopoulou S et al (2017) Comparison of the impact of 68Ga-DOTATATE and 18F-FDG PET/CT on clinical management in patients with neuroendocrine tumors. J Nucl Med 58:91–96

PubMed  Google Scholar 

Kayani I, Bomanji JB, Groves A et al (2008) Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG. Cancer 112:2447–2455

PubMed  Google Scholar 

Zhang P, Yu J, Li J et al (2018) Clinical and prognostic value of PET/CT imaging with combination of (68)Ga-DOTATATE and (18)F-FDG in gastroenteropancreatic neuroendocrine neoplasms. Contrast Media Mol Imaging 2018:2340389

PubMed  PubMed Central  Google Scholar 

Chen H, Pang Y, Wu J et al (2020) Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging 47:1820–1832

PubMed  Google Scholar 

Qin C, Liu F, Huang J et al (2021) A head-to-head comparison of (68)Ga-DOTA-FAPI-04 and (18)F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study. Eur J Nucl Med Mol Imaging 48:3228–3237

CAS  PubMed  Google Scholar 

Lin R, Lin Z, Chen Z et al (2022) [(68)Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of gastric cancer: comparison with [(18)F]FDG PET/CT. Eur J Nucl Med Mol Imaging 49:2960–2971

CAS  PubMed  Google Scholar 

Zhang S, Wang W, Xu T et al (2022) Comparison of diagnostic efficacy of [(68)Ga]Ga-FAPI-04 and [(18)F]FDG PET/CT for staging and restaging of gastric cancer. Front Oncol 12:925100

CAS  PubMed  PubMed Central  Google Scholar 

Tempero MA, Malafa MP, Al-Hawary M et al (2021) Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19:439–457

CAS  PubMed  Google Scholar 

Şahin E, Elboğa U, Çelen YZ, Sever ÖN, Çayırlı YB, Çimen U (2021) Comparison of (68)Ga-DOTA-FAPI and (18)FDG PET/CT imaging modalities in the detection of liver metastases in patients with gastrointestinal system cancer. Eur J Radiol 142:109867

PubMed  Google Scholar 

Meyer C, Dahlbom M, Lindner T et al (2020) Radiation dosimetry and biodistribution of (68)Ga-FAPI-46 PET imaging in cancer patients. J Nucl Med 61:1171–1177

CAS  PubMed  PubMed Central  Google Scholar 

Gilardi L, Airò Farulla LS, Demirci E, Clerici I, Omodeo Salè E, Ceci F (2022) Imaging cancer-associated fibroblasts (CAFs) with FAPi PET. Biomedicines 10:523

Neesse A, Bauer CA, Öhlund D et al (2019) Stromal biology and therapy in pancreatic cancer: ready for clinical translation? Gut 68:159–171